{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:06:30Z","timestamp":1790665590971,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2017,4,3]],"date-time":"2017-04-03T00:00:00Z","timestamp":1491177600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"DNA Therapeutics"},{"DOI":"10.13039\/501100010463","name":"Institut Curie","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100010463","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s00330-017-4792-1","type":"journal-article","created":{"date-parts":[[2017,4,3]],"date-time":"2017-04-03T14:46:28Z","timestamp":1491230788000},"page":"4435-4444","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Potentiation of doxorubicin efficacy in hepatocellular carcinoma by the DNA repair inhibitor DT01 in preclinical models"],"prefix":"10.1007","volume":"27","author":[{"given":"Nirmitha I.","family":"Herath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavien","family":"Devun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Herbette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Christine","family":"Lienafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Chouteau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Sheng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Dutreix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alban","family":"Denys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,3]]},"reference":[{"key":"4792_CR1","doi-asserted-by":"crossref","first-page":"673","DOI":"10.4254\/wjh.v7.i4.673","volume":"7","author":"AI Gomaa","year":"2015","unstructured":"Gomaa AI, Waked I (2015) Recent advances in multidisciplinary management of hepatocellular carcinoma. World J Hepatol 7:673\u2013687","journal-title":"World J Hepatol"},{"key":"4792_CR2","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1158\/1055-9965.EPI-11-0643","volume":"20","author":"MM Center","year":"2011","unstructured":"Center MM, Jemal A (2011) International trends in liver cancer incidence rates. Cancer Epidemiol, Biomarkers Prevent : Publ Am Assoc Cancer Res, Cosponsored Am Soc Prevent Oncol 20:2362\u20132368","journal-title":"Cancer Epidemiol, Biomarkers Prevent : Publ Am Assoc Cancer Res, Cosponsored Am Soc Prevent Oncol"},{"key":"4792_CR3","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000343828","volume":"1","author":"S Lin","year":"2012","unstructured":"Lin S, Hoffmann K, Schemmer P (2012) Treatment of hepatocellular carcinoma: a systematic review. Liver Cancer 1:144\u2013158","journal-title":"Liver Cancer"},{"key":"4792_CR4","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3348\/kjr.2009.10.5.425","volume":"10","author":"SW Shin","year":"2009","unstructured":"Shin SW (2009) The current practice of transarterial chemoembolization for the treatment of hepatocellular carcinoma. Korean J Radiol 10:425\u2013434","journal-title":"Korean J Radiol"},{"key":"4792_CR5","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s11604-011-0010-2","volume":"30","author":"T Toyama","year":"2012","unstructured":"Toyama T, Nitta N, Ohta S et al (2012) Clinical trial of cisplatin-conjugated gelatin microspheres for patients with hepatocellular carcinoma. Jpn J Radiol 30:62\u201368","journal-title":"Jpn J Radiol"},{"key":"4792_CR6","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nrclinonc.2014.122","volume":"11","author":"A Forner","year":"2014","unstructured":"Forner A, Gilabert M, Bruix J, Raoul JL (2014) Treatment of intermediate-stage hepatocellular carcinoma. Nat Rev Clin Oncol 11:525\u2013535","journal-title":"Nat Rev Clin Oncol"},{"key":"4792_CR7","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0168-8278(98)80123-2","volume":"29","author":"KJ Oldhafer","year":"1998","unstructured":"Oldhafer KJ, Chavan A, Fruhauf NR et al (1998) Arterial chemoembolization before liver transplantation in patients with hepatocellular carcinoma: marked tumor necrosis, but no survival benefit? J Hepatol 29:953\u2013959","journal-title":"J Hepatol"},{"key":"4792_CR8","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s002709900286","volume":"21","author":"A Veltri","year":"1998","unstructured":"Veltri A, Grosso M, Martina MC et al (1998) Effect of preoperative radiological treatment of hepatocellular carcinoma before liver transplantation: a retrospective study. Cardiovasc Intervent Radiol 21:393\u2013398","journal-title":"Cardiovasc Intervent Radiol"},{"key":"4792_CR9","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.jhep.2011.07.031","volume":"56","author":"U Asghar","year":"2012","unstructured":"Asghar U, Meyer T (2012) Are there opportunities for chemotherapy in the treatment of hepatocellular cancer? J Hepatol 56:686\u2013695","journal-title":"J Hepatol"},{"key":"4792_CR10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1475-2867-12-47","volume":"12","author":"AM Osman","year":"2012","unstructured":"Osman AM, Bayoumi HM, Al-Harthi SE, Damanhouri ZA, Elshal MF (2012) Modulation of doxorubicin cytotoxicity by resveratrol in a human breast cancer cell line. Cancer Cell Int 12:47","journal-title":"Cancer Cell Int"},{"key":"4792_CR11","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jvir.2013.01.494","volume":"24","author":"JL Weintraub","year":"2013","unstructured":"Weintraub JL, Salem R (2013) Treatment of hepatocellular carcinoma combining sorafenib and transarterial locoregional therapy: state of the science. J Vasc Intervention Radiol : JVIR 24:1123\u20131134","journal-title":"J Vasc Intervention Radiol : JVIR"},{"key":"4792_CR12","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1158\/1078-0432.CCR-08-2108","volume":"15","author":"M Quanz","year":"2009","unstructured":"Quanz M, Berthault N, Roulin C et al (2009) Small-molecule drugs mimicking DNA damage: a new strategy for sensitizing tumors to radiotherapy. Clin Cancer Res : Off J Am Assoc Cancer Res 15:1308\u20131316","journal-title":"Clin Cancer Res : Off J Am Assoc Cancer Res"},{"key":"4792_CR13","doi-asserted-by":"crossref","first-page":"e6298","DOI":"10.1371\/journal.pone.0006298","volume":"4","author":"M Quanz","year":"2009","unstructured":"Quanz M, Chassoux D, Berthault N, Agrario C, Sun JS, Dutreix M (2009) Hyperactivation of DNA-PK by double-strand break mimicking molecules disorganizes DNA damage response. PLoS One 4:e6298","journal-title":"PLoS One"},{"issue":"15","key":"4792_CR14","doi-asserted-by":"crossref","first-page":"7344","DOI":"10.1093\/nar\/gkt522","volume":"41","author":"A Croset","year":"2013","unstructured":"Croset A, Cordelieres FP, Berthault N et al (2013) Inhibition of DNA damage repair by artificial activation of PARP with siDNA. Nucleic Acids Res 41(15):7344\u20137355, Epub 2013\/06\/14","journal-title":"Nucleic Acids Res"},{"key":"4792_CR15","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/cgt.2011.39","volume":"18","author":"N Berthault","year":"2011","unstructured":"Berthault N, Maury B, Agrario C et al (2011) Comparison of distribution and activity of nanoparticles with short interfering DNA (Dbait) in various living systems. Cancer Gene Ther 18:695\u2013706","journal-title":"Cancer Gene Ther"},{"key":"4792_CR16","doi-asserted-by":"crossref","first-page":"e40567","DOI":"10.1371\/journal.pone.0040567","volume":"7","author":"N Coquery","year":"2012","unstructured":"Coquery N, Pannetier N, Farion R et al (2012) Distribution and radiosensitizing effect of cholesterol-coupled Dbait molecule in rat model of glioblastoma. PLoS One 7:e40567","journal-title":"PLoS One"},{"key":"4792_CR17","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s00535-011-0483-x","volume":"47","author":"F Devun","year":"2012","unstructured":"Devun F, Bousquet G, Biau J et al (2012) Preclinical study of the DNA repair inhibitor Dbait in combination with chemotherapy in colorectal cancer. J Gastroenterol 47:266\u2013275","journal-title":"J Gastroenterol"},{"key":"4792_CR18","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1148\/radiol.13130805","volume":"270","author":"F Devun","year":"2014","unstructured":"Devun F, Biau J, Huerre M et al (2014) Colorectal cancer metastasis: the DNA repair inhibitor Dbait increases sensitivity to hyperthermia and improves efficacy of radiofrequency ablation. Radiology 270:736\u2013746","journal-title":"Radiology"},{"key":"4792_CR19","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1007\/s00270-012-0343-y","volume":"35","author":"PP Rao","year":"2012","unstructured":"Rao PP, Pascale F, Seck A et al (2012) Irinotecan loaded in eluting beads: preclinical assessment in a rabbit VX2 liver tumor model. Cardiovasc Intervent Radiol 35:1448\u20131459","journal-title":"Cardiovasc Intervent Radiol"},{"key":"4792_CR20","doi-asserted-by":"crossref","unstructured":"Bize P, Duran R, Fuchs K, et al. (2016) Antitumoral effect of sunitinib-eluting beads in the rabbit VX2 tumor model. Radiology: 150361","DOI":"10.1148\/radiol.2016150361"},{"key":"4792_CR21","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1158\/1535-7163.MCT-15-0408","volume":"15","author":"NI Herath","year":"2016","unstructured":"Herath NI, Devun F, Lienafa MC et al (2016) The DNA repair inhibitor DT01 as a novel therapeutic strategy for chemosensitization of colorectal liver metastasis. Mol Cancer Ther 15:15\u201322","journal-title":"Mol Cancer Ther"},{"key":"4792_CR22","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/BF02614220","volume":"13","author":"LH Ramirez","year":"1995","unstructured":"Ramirez LH, Julieron M, Bonnay M et al (1995) Stimulation of tumor growth in vitro and in vivo by suramin on the VX2 model. Investig New Drugs 13:51\u201353","journal-title":"Investig New Drugs"},{"key":"4792_CR23","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S1051-0443(07)61299-8","volume":"11","author":"JF Geschwind","year":"2000","unstructured":"Geschwind JF, Artemov D, Abraham S et al (2000) Chemoembolization of liver tumor in a rabbit model: assessment of tumor cell death with diffusion-weighted MR imaging and histologic analysis. J Vasc Intervention Radiol : JVIR 11:1245\u20131255","journal-title":"J Vasc Intervention Radiol : JVIR"},{"key":"4792_CR24","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1080\/02841850801958890","volume":"49","author":"B Wang","year":"2008","unstructured":"Wang B, Xu H, Gao ZQ, Ning HF, Sun YQ, Cao GW (2008) Increased expression of vascular endothelial growth factor in hepatocellular carcinoma after transcatheter arterial chemoembolization. Acta Radiol 49:523\u2013529","journal-title":"Acta Radiol"},{"key":"4792_CR25","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.taap.2012.10.025","volume":"266","author":"VG Desai","year":"2013","unstructured":"Desai VG, Herman EH, Moland CL (2013) Development of doxorubicin -induced chronic cardiotoxicity in the B6C3F1 mouse model. Toxicol Appl Pharmacol 266:109\u2013121","journal-title":"Toxicol Appl Pharmacol"},{"key":"4792_CR26","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0027-5107(93)90049-L","volume":"285","author":"M Fenech","year":"1993","unstructured":"Fenech M (1993) The cytokinesis-block micronucleus technique: a detailed description of the method and its application to genotoxicity studies in human populations. Mutat Res 285:35\u201344","journal-title":"Mutat Res"},{"key":"4792_CR27","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1667\/RR13860.1","volume":"183","author":"HC Turner","year":"2015","unstructured":"Turner HC, Shuryak I, Taveras M et al (2015) Effect of dose rate on residual gamma-H2AX levels and frequency of micronuclei in X-irradiated mouse lymphocytes. Radiat Res 183:315\u2013324","journal-title":"Radiat Res"},{"key":"4792_CR28","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/j.cellsig.2007.05.013","volume":"19","author":"K Holmes","year":"2007","unstructured":"Holmes K, Roberts OL, Thomas AM, Cross MJ (2007) Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition. Cell Signal 19:2003\u20132012","journal-title":"Cell Signal"},{"key":"4792_CR29","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1756-9966-32-16","volume":"32","author":"JS Chu","year":"2013","unstructured":"Chu JS, Ge FJ, Zhang B et al (2013) Expression and prognostic value of VEGFR-2, PDGFR-beta, and c-Met in advanced hepatocellular carcinoma. J Experiment Clin Cancer Res : CR 32:16","journal-title":"J Experiment Clin Cancer Res : CR"},{"key":"4792_CR30","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.neo.2014.08.008","volume":"16","author":"J Biau","year":"2014","unstructured":"Biau J, Devun F, Jdey W et al (2014) A preclinical study combining the DNA repair inhibitor Dbait with radiotherapy for the treatment of melanoma. Neoplasia 16:835\u2013844","journal-title":"Neoplasia"},{"key":"4792_CR31","doi-asserted-by":"crossref","first-page":"12927","DOI":"10.18632\/oncotarget.7340","volume":"7","author":"C Viallard","year":"2016","unstructured":"Viallard C, Chezal JM, Mishellany F et al (2016) Targeting DNA repair by coDbait enhances melanoma targeted radionuclide therapy. Oncotarget 7:12927\u201312936","journal-title":"Oncotarget"},{"key":"4792_CR32","doi-asserted-by":"crossref","first-page":"e28947","DOI":"10.1371\/journal.pone.0028947","volume":"6","author":"MT Dellinger","year":"2011","unstructured":"Dellinger MT, Brekken RA (2011) Phosphorylation of Akt and ERK1\/2 is required for VEGF-A\/VEGFR2-induced proliferation and migration of lymphatic endothelium. PLoS One 6:e28947","journal-title":"PLoS One"},{"key":"4792_CR33","doi-asserted-by":"crossref","first-page":"e47516","DOI":"10.1371\/journal.pone.0047516","volume":"7","author":"P Pratheeshkumar","year":"2012","unstructured":"Pratheeshkumar P, Budhraja A, Son YO et al (2012) Quercetin inhibits angiogenesis mediated human prostate tumor growth by targeting VEGFR- 2 regulated AKT\/mTOR\/P70S6K signaling pathways. PLoS One 7:e47516","journal-title":"PLoS One"},{"key":"4792_CR34","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nm.1947","volume":"15","author":"M Economopoulou","year":"2009","unstructured":"Economopoulou M, Langer HF, Celeste A et al (2009) Histone H2AX is integral to hypoxia-driven neovascularization. Nat Med 15:553\u2013558","journal-title":"Nat Med"},{"key":"4792_CR35","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.18632\/oncotarget.2942","volume":"6","author":"H Xiao","year":"2015","unstructured":"Xiao H, Tong R, Ding C et al (2015) gamma-H2AX promotes hepatocellular carcinoma angiogenesis via EGFR\/HIF-1alpha\/VEGF pathways under hypoxic condition. Oncotarget 6:2180\u20132192","journal-title":"Oncotarget"},{"key":"4792_CR36","first-page":"443","volume":"86","author":"PM Glazer","year":"2013","unstructured":"Glazer PM, Hegan DC, Lu Y, Czochor J, Scanlon SE (2013) Hypoxia and DNA repair. Yale J Biol Med 86:443\u2013451","journal-title":"Yale J Biol Med"},{"key":"4792_CR37","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/nrc2344","volume":"8","author":"RG Bristow","year":"2008","unstructured":"Bristow RG, Hill RP (2008) Hypoxia and metabolism. Hypoxia, DNA repair and genetic instability. Nat Rev Cancer 8:180\u2013192","journal-title":"Nat Rev Cancer"},{"key":"4792_CR38","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1158\/0008-5472.CAN-07-5472","volume":"68","author":"N Chan","year":"2008","unstructured":"Chan N, Koritzinsky M, Zhao H et al (2008) Chronic hypoxia decreases synthesis of homologous recombination proteins to offset chemoresistance and radioresistance. Cancer Res 68:605\u2013614","journal-title":"Cancer Res"},{"key":"4792_CR39","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1007\/BF01297149","volume":"36","author":"RG Simonetti","year":"1991","unstructured":"Simonetti RG, Camma C, Fiorello F, Politi F, D'Amico G, Pagliaro L (1991) Hepatocellular carcinoma. a worldwide problem and the major risk factors. Dig Dis Sci 36:962\u2013972","journal-title":"Dig Dis Sci"},{"key":"4792_CR40","doi-asserted-by":"crossref","unstructured":"Gholamrezanezhad A, Mirpour S, Geschwind JH, et al. (2016) Evaluation of 70-150-mum doxorubicin-eluting beads for transcatheter arterial chemoembolization in the rabbit liver VX2 tumour model. Europ Radiol","DOI":"10.1007\/s00330-015-4197-y"},{"key":"4792_CR41","doi-asserted-by":"crossref","unstructured":"Brown KT, Do RK, Gonen M, et al. (2016) Randomized trial of hepatic artery embolization for hepatocellular carcinoma using doxorubicin-eluting microspheres compared with embolization with microspheres alone. J Clin Oncol : Off J Am Soc Clin Oncol","DOI":"10.1200\/JCO.2015.64.0821"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00330-017-4792-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-017-4792-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-017-4792-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T19:26:39Z","timestamp":1589743599000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00330-017-4792-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,3]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["4792"],"URL":"https:\/\/doi.org\/10.1007\/s00330-017-4792-1","relation":{},"ISSN":["0938-7994","1432-1084"],"issn-type":[{"value":"0938-7994","type":"print"},{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,3]]}}}